A pilot feasibility randomised controlled trial of bone antiresorptive agents on bone turnover markers in critically ill women
Description
Critical illness is associated with increased bone turnover, loss of bone density, and increased risk of fragility fractures. The impact of bone antiresorptive agents in this population is not established. This trial examined the efficacy